Cite Filings / LIMN
Feed Companies Filings Check
Sign in

CIK 0001971387

  • Emerging growth company

Liminatus Pharma, Inc.

Sign in to watch
Ticker
LIMN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 213-273-5453
Business address
12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
Former names
Iris Parent Holding Corp.

Securities

  • LIMN Class A Common Stock Nasdaq
  • LIMNW Warrants Nasdaq
Filings Financials Insiders Search text
All 109 Financials 31 Shareholder Meetings 2 Executive Compensation 27 Insider Trading 16 Beneficial Ownership Interest 11 Business Combinations 31 Public Offerings 31 Mutual Funds and ETFs 1 Others 13
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2024-08-09
  3. CORRESP Other Correspondence Between Filers and SEC Staff 2024-08-08
  4. UPLOAD Other SEC-generated Letter 2024-08-08
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2024-08-07
  6. UPLOAD Other SEC-generated Letter 2024-08-05
  7. CORRESP Other Correspondence Between Filers and SEC Staff 2024-07-25
  8. UPLOAD Other SEC-generated Letter 2024-07-11
  9. CORRESP Other Correspondence Between Filers and SEC Staff 2024-06-14
  10. UPLOAD Other SEC-generated Letter 2023-12-04
  11. CORRESP Other Correspondence Between Filers and SEC Staff 2023-11-08
  12. UPLOAD Other SEC-generated Letter 2023-05-30

Page 2 of 2 · 31 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…